Item 8.01 Other Events.
On March 9, 2009, Medtronic, Inc. (the "Company") agreed to sell $550,000,000
principal amount of its 4.50% Senior Notes due 2014 (the "2014 Notes"),
$400,000,000 principal amount of its 5.60% Senior Notes due 2019 (the "2019
Notes") and $300,000,000 principal amount of its 6.50% Senior Notes due 2039
(the "2039 Notes," and together with the 2014 Notes and the 2019 Notes, the
"Notes") pursuant to an Underwriting Agreement, dated March 9, 2009 (the
"Underwriting Agreement"), among the Company, Deutsche Bank Securities Inc. and
J.P. Morgan Securities Inc., as representatives of the underwriters named
therein. The Company's representations in the Underwriting Agreement were made
as of the date thereof in connection with negotiating the contract, are subject
to qualifications and limitations agreed to by the parties, may have been used
for purposes of allocating risk between the parties rather than for the purpose
of establishing matters as facts, and should not be relied upon as though such
representations were made to any holders of securities of the Company. You
should read the information provided in the filing and in the Company's other
filings with the Securities and Exchange Commission.
The sale of the Notes closed on March 12, 2009. The Notes were issued pursuant
to an Indenture dated March 12, 2009, as supplemented by the First Supplemental
Indenture dated March 12, 2009, among the Company and Wells Fargo Bank, National
Association, as trustee. The offer and sale of the Notes have been registered
under the Securities Act of 1933, as amended, pursuant to a registration
statement on Form S-3ASR (No. 333-157777) filed with the Securities and Exchange
Commission on March 9, 2009.
The purpose of this Current Report is to file with the Securities and Exchange
Commission the Underwriting Agreement and the First Supplemental Indenture,
which includes the form of Global Notes, copies of which attached hereto as
Exhibits 1.1 and 4.1, respectively. A copy of the press release related to this
offering is also attached hereto as Exhibit 99.1.
The foregoing description of the issuance, sale and term of the Notes does not
purport to be complete and is qualified in its entirety by reference to the
Underwriting Agreement, the Indenture and the Supplemental Indenture entered
into in connection therewith.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
1.1 Underwriting Agreement, dated March 9, 2009, among the Company, Deutsche
Bank Securities Inc. and J.P. Morgan Securities Inc., as representatives of the
underwriters named therein.
4.1 First Supplemental Indenture, dated March 12, 2009, among the Company and
Wells Fargo Bank, National Association, as trustee (which includes the form of
Global Notes).
99.1 Press Release of the Company dated March 9, 2009.
Table of Contents